Trieste, Italy
26 – 28 October 2027
The subject areas of the meeting will mostly be concerned with the role played by TDP-43 in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Its involvement in these and other neurodegenerative diseases, such as Alzheimer’s Disease and Parkinson’s Disease, points to TDP-43 as a salient neuropathological protein. As a result, there is growing interest in developing new approaches to understand the consequences of TDP-43 mislocalization and aggregation in disease. Even so, the precise function of TDP-43 in normal cells remains unclear, as are the initial events driving TDP-43 mislocalization and aggregation in disease, and the impact of TDP-43 pathology on neuronal integrity. The meeting organized in Trieste represents an ideal opportunity to discuss ongoing epidemiological, clinical, pathological, neuroimaging, and genetic investigations of this protein. This venue will also serve as a platform for presenting and discussing the latest TDP-43-based therapeutic strategies that are being developed and tested in disease models.
Topics
- Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)
- Events driving TDP-43 mislocalization and aggregation in disease
- Impact of TDP-43 pathology on neuronal integrity new therapeutic directions
Participants
- PhD and Post-docs in neurodegeneration
- Clinicians in neurodegenerative diseases
- Basic scientists in protein aggregation
- Basic scientists in neurodegeneration pathways
Scientific Organisers
Emanuele Buratti (ICGEB Trieste, Italy), Yuna Ayala
(Saint Louis University, MO, USA), Sami Barmada (University of Michigan School of Medicine, Ann Arbor, MI, USA), Christopher Donnelly (University of Pittsburgh School of Medicine, USA) and Jemeen Sreedharan (King’s College London, UK)
Meeting Secretariat
ICGEB Meetings and Courses Unit
Tel: +39-040-3757333
Fax: +39-040-226555
Email: [email protected]
Follow ICGEB events on social media: #ICGEBmeeting
